These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8296903)

  • 41. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
    Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
    J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pituitary gonadotropin response to luteinizing hormone-releasing hormone (LH-RH) in males with azo- and oligospermia.
    Dubowitz B; Distiller LA; Sagel J; Miller N; Gecelter L
    Int J Fertil; 1975; 20(1):1-4. PubMed ID: 4378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Luteinizing hormone releasing hormone and human behavior.
    Tiwary CM; Dyksterhuis J
    Am J Dis Child; 1988 Jul; 142(7):699-700. PubMed ID: 3289371
    [No Abstract]   [Full Text] [Related]  

  • 46. Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps.
    Akhtar FB; Marshall GR; Wickings EJ; Nieschlag E
    J Clin Endocrinol Metab; 1983 Mar; 56(3):534-40. PubMed ID: 6401760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recovery of pituitary-gonadal function in male rats after long-term suppression induced by a single injection of microcapsules of LH-RH antagonist cetrorelix (SB-75).
    Pinski J; Yano T; Szepeshazi K; Groot K; Schally AV
    J Androl; 1993; 14(3):164-9. PubMed ID: 8407570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
    Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study of the effects of gonadotropin-releasing hormone on human mood and behavior.
    McAdoo BC; Doering CH; Kraemer HC; Dessert N; Brodie HK; Hamburg DA
    Psychosom Med; 1978 May; 40(3):199-209. PubMed ID: 351663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term effect of pharmacologically induced alterations in testosterone levels on common blood biomarkers in a controlled healthy human model.
    Sahlin KB; Pla I; Sanchez A; Pawłowski K; Leijonhufvud I; Appelqvist R; Marko-Varga G; Giwercman A; Malm J
    Scand J Clin Lab Invest; 2020 Feb; 80(1):25-31. PubMed ID: 31738571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testosterone-estradiol filled polydimethylsiloxane subdermal implants: effect on fertility and masculine sexual and aggressive behavior of male rats.
    Ewing LL; Gorski RA; Sbordone RJ; Tyler JV; Desjardins C; Robaire B
    Biol Reprod; 1979 Nov; 21(4):765-72. PubMed ID: 575051
    [No Abstract]   [Full Text] [Related]  

  • 52. Testosterone rapidly increases neural reactivity to threat in healthy men: a novel two-step pharmacological challenge paradigm.
    Goetz SM; Tang L; Thomason ME; Diamond MP; Hariri AR; Carré JM
    Biol Psychiatry; 2014 Aug; 76(4):324-31. PubMed ID: 24576686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone may improve sexual function and mood in older men with low levels.
    Mayor S
    BMJ; 2016 Feb; 352():i989. PubMed ID: 26893440
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood levels of testosterone after Gn-RH injection in boars with or without libido.
    Einarsson S; Larsson K
    Acta Vet Scand; 1980; 21(3):375-9. PubMed ID: 7004148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychosexual effects of three doses of testosterone cycling in normal men.
    Yates WR; Perry PJ; MacIndoe J; Holman T; Ellingrod V
    Biol Psychiatry; 1999 Feb; 45(3):254-60. PubMed ID: 10023498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypothalamic modulation of nociception and reproduction in cluster headache. II. Testosterone-induced increase of sexual activity in males with cluster headache.
    Nicolodi M; Sicuteri F; Poggioni M
    Cephalalgia; 1993 Aug; 13(4):258-60. PubMed ID: 8374941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potency differences in GnRH antagonists?
    Behre HM; Nieschlag E
    Fertil Steril; 1994 Jul; 62(1):205-6. PubMed ID: 8005298
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical effects of amphetamine and L-DOPA on sexuality and aggression.
    Angrist B; Gershon S
    Compr Psychiatry; 1976; 17(6):715-22. PubMed ID: 991603
    [No Abstract]   [Full Text] [Related]  

  • 59. Sexual motivation: problem solved and new problems introduced.
    Pfaff D; Saad F
    Horm Mol Biol Clin Investig; 2020 Jan; 41(2):. PubMed ID: 31926079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The gender conundrum.
    Fitzpatrick L
    Time; 2007 Nov; 170(21):59. PubMed ID: 18074643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.